User:Meljoymul

--MJMullen 10:51, 4 June 2008 (UTC)

socks silicone socks


Definition of a Silicone Sock is as follows, A Silicone Sock consist of 2 parts #1 a basic white cotton sock and #2 a 100% rubber sole applied to the underside of the sock it is about 1/8 inch in thickness covering the entire underside of a sock. The main purpose for Silicone Socks are to assist in the healing of feet. Many individuals suffer from a variety of foot painful foot ailments, for example diabetic's suffer from foot ulcers that are exposed to infection without a 20 week treatment of a gel substance medication. With Silicone Socks the rubber sole locks in the medication therefore medications and foot powders cannot escape through the underside of the sock to read more about diabetic foot follow the link below provided by the FDA.

Adults with diabetes need to take special care of their feet.

People with diabetes are at risk for foot injuries due to numbness caused by nerve damage (diabetic neuropathy) and low blood flow to the legs and feet. The most serious injury is a foot ulcer. Diabetic foot ulcers are at very high risk of becoming infected, and sometimes they cannot be healed. Non-healing foot ulcers are a frequent cause of amputation in people with diabetes. Patients with foot ulcers may use wound dressings, skin substitutes, or other treatments to protect and heal their skin.

Wound dressings are medical devices that are used to protect ulcerated skin and assist in its healing. They can range from simple bandages that you can buy in the drug store to complex materials that contain antibacterial and antiviral substances.

Skin substitutes are products that help in closing the wounds of slow healing ulcers in patients with diabetes. They are made from human cells known as fibroblasts that are placed on a dissolvable mesh material. When the mesh material is placed on the ulcer, it is gradually absorbed and the human cells grow and replace the damaged tissue in the ulcer.

FDA has cleared one gel product (becaplermin) that is used as a treatment for diabetic foot ulcers. This product contains genetically engineered platelet-derived growth factor, one of the proteins the body produces to encourage new tissue growth. Clinical studies of the product indicated that the likelihood of complete ulcer closure, after up to 20 weeks of treatment, was greater when becaplermin is used.